These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4548779)

  • 1. [Long-term treatment using Arwin of patients with chronic peripheral arterial blood circulation disorders].
    Ehrly AM
    Subsid Med; 1974; 4():56-7. PubMed ID: 4548779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modification of blood coagulation through Arwin].
    Vinazzer H
    Subsid Med; 1974; 4():53-5. PubMed ID: 4450561
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dose-response relationship of subcutaneously administered Arwin in patients with chronic arterial blood circulation disorders].
    Ehrly AM
    Vasa; 1975; 4(2):161-7. PubMed ID: 1136569
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
    Ehringer H; Dudczak E; Lechner K; Widhalm F
    Verh Dtsch Ges Inn Med; 1972; 78():624-7. PubMed ID: 4677225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H; Dudczak R; Lechner K
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improvement of blood viscosity through Arvin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Inn Med; 1972; 78():620-4. PubMed ID: 4677224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with arwin in combination with thrombolytic therapy].
    Keil-Kuri E; Hess H
    Verh Dtsch Ges Inn Med; 1974; 80():1470-2. PubMed ID: 4454460
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Therapeutic defibrination with Ancrod].
    Ehrly AM
    Dtsch Med Wochenschr; 1974 Jan; 99(3):112-3. PubMed ID: 4812781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on indirect long-term anticoagulant therapy in ambulatory peripheral chronic arteriosclersis obliterans patients].
    Raso AM; Silvestrini P
    Angiologia; 1968; 20(6):301-16. PubMed ID: 5747170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():243-5. PubMed ID: 4450660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Induction of microthrombi through arwin infusion in the rabbit].
    Müller-Berghaus G; Hocke M; Lasch HG
    Verh Dtsch Ges Inn Med; 1972; 78():1614-6. PubMed ID: 4665622
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fluvographic and oscillographic studies before and following intra-arterial injections of methylprednisolone and dihydro-derivatives of ergotoxin group in peripheral arterial blood circulation disorders].
    Knoth W; Schafé MK; Höland H
    Z Haut Geschlechtskr; 1966 Feb; 40(3):57-68. PubMed ID: 4963747
    [No Abstract]   [Full Text] [Related]  

  • 13. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study on the effects of nicergoline on muscular blood circulation in peripheral arterial diseases].
    Stancanelli V; Bagni B
    Minerva Cardioangiol; 1973 Sep; 21(9):581-4. PubMed ID: 4745001
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-biological evaluation of the effect of Triflusal in arteriosclerotic patients with a high risk of thrombosis. A long-term study].
    Sala-Planell E; Latorre J; Marinel-lo J; Rutllant ML; Miralles J; Ramírez de Avellano R
    Angiologia; 1981; 33(2):71-8. PubMed ID: 7235297
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical tests using pyridinol carbamate on the arterial circulation and blood coagulation in patients with arteriosclerosis obliterans].
    De Soldati L; Castro CM; Grilli H; Reussi J
    Prensa Med Argent; 1969 May; 56(12):546-53. PubMed ID: 5343928
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improvement of flow properties of human blood by subcutaneous administration of arwin].
    Ehrly AM; Jung HJ
    Verh Dtsch Ges Inn Med; 1973; 79():1397-400. PubMed ID: 4799541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on drug controlled blood distribution as a conservative therapeutic principle in arteriosclerosis obliterans].
    Mörl H; Preuss EG; Bartusch M; Schneider W
    Z Kreislaufforsch; 1972 Feb; 61(2):144-52. PubMed ID: 5026177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.